Korro Bio Inc.

NASDAQ: KRRO · Real-Time Price · USD
20.27
0.39 (1.96%)
At close: Aug 15, 2025, 3:59 PM
20.66
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

Korro Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.46M 2.55M 2.27M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.42M 4.65M
Cost of Revenue
n/a n/a n/a 865K 721K 726K 1.75M 1.02M 1.13M 1.63M 1.28M 1.18M 1.36M 1.32M 1.31M 809K n/a 4.65M
Gross Profit
260K 2.55M 2.27M -865K -721K -726K -1.75M -1.02M -1.13M -1.63M -1.28M -1.18M -1.36M -1.32M -1.31M -809K 9.42M n/a
Operating Income
-27.2M -25.02M -23.04M -23.29M -24.13M -21.45M -39.53M -12.66M -11.47M -16.54M -18.2M -20.27M -21.27M -23.26M -21.36M -24.99M -17.48M -20.2M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 448K 346K 523K 456K 351K n/a n/a 82K 172K 118K 25K
Pretax Income
-25.77M -23.39M -21.1M -21.01M -21.8M -19.54M -39.21M -11.62M -10.79M -19.52M -17.36M -19.57M -21.28M -23.37M -21.5M -25.15M -17.65M -20.38M
Net Income
-25.77M -23.39M -21.2M -21M -21.83M -19.56M -39.22M -11.61M -10.8M -19.54M -17.36M -19.55M -21.29M -23.39M -21.5M -25.16M -17.66M -20.38M
Selling & General & Admin
7.63M 7.83M 8.35M 7.33M 6.99M 7.88M 786K 9.2M 6.18M 6.71M 6.65M 7.77M 7.04M 8.6M 7.75M 8.97M 8.86M 9.36M
Research & Development
21.03M 19.74M 16.96M 15.96M 17.14M 13.57M 36.99M 2.44M 4.16M 8.2M 10.26M 11.32M 12.87M 13.34M 12.3M 15.21M 16.98M 14.83M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
28.66M 27.57M 25.31M 23.29M 24.13M 21.45M 37.78M 11.64M 10.35M 14.91M 16.92M 19.09M 19.91M 21.94M 20.05M 24.18M 25.84M 24.18M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 284K 312K 263K n/a n/a 182K 182K 182K 218K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 3.8M 777.78K 9.19M 6.18M 6.71M 6.65M 7.77M 1.37M 4.54M n/a n/a n/a n/a
Cost & Expenses
28.66M 27.57M 25.31M 23.29M 24.13M 21.45M 39.53M 12.66M 11.47M 16.54M 18.2M 20.27M 21.27M 23.26M 21.36M 24.99M 26.9M 24.85M
Income Tax Expense
-1K n/a 103K -9K 30K 17K 5K -7K 5K 24K 7K -23K 2K 12K 2K 3K 10K n/a
Shares Outstanding (Basic)
9.39M 9.38M 8.92M 9.3M 8.99M 8.02M 8.02M 5.72M 5.56M 5.46M 5.4M 5.23M 699.53K 696.21K 691.92K 688.97K 684.77K 682.31K
Shares Outstanding (Diluted)
9.39M 9.38M 8.92M 9.3M 8.99M 8.02M 8.02M 5.72M 5.56M 5.46M 5.4M 5.23M 699.53K 696.21K 691.92K 688.97K 684.77K 682.31K
EPS (Basic)
-2.74 -2.49 -2.26 -2.26 -2.43 -2.44 -4.89 -2.03 -1.94 -3.58 -3.21 -3.74 -30.43 -33.59 -31.07 -36.51 -25.78 -29.86
EPS (Diluted)
-2.74 -2.49 -2.26 -2.26 -2.43 -2.44 -4.89 -2.03 -1.94 -3.58 -3.21 -3.74 -30.43 -33.59 -31.07 -36.51 -25.78 -29.86
EBITDA
-27.2M -23.8M -21.79M -22.43M -23.4M -20.73M -36.43M -17.57M -17.49M -19.28M -15.76M -18.13M -19.72M -21.88M -20.01M -24.16M -16.41M -19.49M
EBIT
-25.77M -25.02M -23.04M -23.29M -24.13M -21.45M -38.18M -18.49M -18.41M -20.09M -17.04M -19.31M -21.07M -23.2M -21.32M -24.97M -17.46M -20.16M
Depreciation & Amortization
1.2M 1.23M 1.25M 865K 721K 726K 1.75M 919K 1.13M 1.63M 1.28M 1.18M 1.36M 1.32M 1.31M 809K 1.06M 668K